Analysts at Precedence Research expect the gene-editing market to grow 15.7% annually and reach $40.1 billion by 2034, ...

Gene editing is an advanced medical technique within ... Its cell programming platform produces a variety of products, such as food ingredients, therapeutics, and chemicals. Ginkgo Bioworks ...

We recently published a list of 8 Best Gene-Editing Stocks to Buy. In this article, we are going to take a look at where ...

At meeting on human embryo editing, CRISPR pioneer says science is a long way from knowing if germline DNA can be safely ...

Nanotechnology offers a next-gen solution to plant genome editing challenges by enabling precise, efficient delivery of CRISPR, RNA, and DNA tools using nanoparticles like AuNPs, CNTs, and lipid ...

Canadian consumers are largely fine with pork from gene-edited pigs — at least once the science and benefits are explained to ...

Canadian and U.S. farmers may get pigs resistant to porcine reproductive and respiratory syndrome (PRRS) in the ...

Base editing corrected a mutation that causes macular degeneration, highlighting the potential of gene therapy to treat ...

In this week’s edition of the biotech bi-weekly, learn more about Thermo Fisher’s new system for automating complex sample ...

Expanding CRISPR's Potential Since its discovery, CRISPR (“Clustered Regularly Interspaced Short Palindromic Repeats”), which ...

Intellia Therapeutics is a clinical-stage biotech company developing CRISPR-Cas9 gene-editing products designed for both in vivo and ex vivo applications. Its lead clinical program is Nex-z ...